Artisan Partners Limited Partnership Merus N.V. Transaction History

Artisan Partners Limited Partnership

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$12.8 - $23.66 $1.79 Million - $3.31 Million	139,734 New	139,734 $2.16 Million
Q4 2020 Feb 10, 2021	SELL	$11.4 - $18.36 $3.26 Million - $5.25 Million	-286,175 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$10.57 - $16.0 $748,334 - $1.13 Million	70,798 Added 32.87%	286,175 $3.43 Million
Q2 2020 Aug 12, 2020	BUY	$10.5 - $17.36 $2.26 Million - $3.74 Million	215,377 New	215,377 $3.47 Million

200

61.9M

243K

300K

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $2.28B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Artisan Partners Limited Partnership with notifications on news.